Akt2 encodes a protein-serine/threonine kinase containing a pleckstrin homology domain characteristic of many signaling molecules. Although there has been extensive interest in the mechanism by which the closely-related Akt kinase participates in phosphatidylinositol 3-kinasemediated signaling, comparatively little is known regarding the expression and function of Akt2. This manuscript is the ®rst to describe Akt2 mRNA expression in the developing mouse and the activation of AKT2 by insulin. These studies demonstrate that Akt2 is especially abundant in brown fat and, to a lesser extent, skeletal muscle and liver, tissues which are highly insulinresponsive and play a role in glucose metabolism. Endogenous Akt2 expression also is upregulated in fully-dierentiated C2C12 myotubes and 3T3-L1 adipocytes, suggesting that these murine cell lines represent useful in vitro models for studies of Akt2 function. We show that HA-tagged AKT2 is activated in response to insulin stimulation in vitro and that activation of AKT2 is not induced in cells pretreated with wortmannin, an inhibitor of phosphatidylinositol 3-kinase. These data suggest that Akt2 expression is fundamental to the dierentiated state of fat and muscle cells and that activation of AKT2 kinase by insulin is mediated through the phosphatidylinositol 3-kinase signaling pathway.
Akt de®nes a family of related genes that are highly conserved in evolution. In man, two genes have been identi®ed: AKT1 and AKT2 (Staal, 1987) . AKT1 is the true human homologue of mouse Akt (Cheng et al., 1992; Bellacosa et al., 1993) . The Akt/AKT1 gene is identical to RAC-PKa, which was cloned by virtue of its homology to genes encoding protein kinase A (PKA) and PKC (Jones et al., 1991) , and the PKBa gene (Coer and Woodgett, 1991) . AKT2 is identical to RAC-PKb (Jones et al., 1991; Cheng et al., 1992) , exhibiting 78% and 82% identity to AKT1 at the nucleotide and amino acid levels, respectively. Homologues of human AKT2 have been isolated from both rat and mouse (Konishi et al., 1994; Altomare et al., 1995) .
The Akt family encodes proteins containing an amino-terminal pleckstrin homology (PH) domain characteristic of many signaling molecules (Haslam et al., 1993; Mayer et al., 1993) , linked via a helical structure motif to a protein-serine/threonine kinase domain and carboxyl-terminal tail (C-tail) found in members of the PKC family of kinases (Cheng et al., 1992; Bellacosa et al., 1993) . The C-tail appears to have a regulatory role (Datta et al., 1996; Cheng et al., 1997) . The most divergent regions between Akt/AKT1 and mouse Akt2 are the amino-terminal domain and C-tail, suggesting that these two regions may confer functional dierences between these two related proteins.
There has been extensive interest in the mechanism by which Akt/AKT1 participates in mitogenic signaling. This kinase can be activated by serum, various growth factors including platelet derived growth factor (PDGF), epidermal growth factor, basic ®broblast growth factor, insulin, and insulin-like growth factor-1 (reviewed in Franke et al., 1997; Hemmings, 1997) , as well as by cellular stress such as heat shock and hyperosmolarity Matsuzaki et al., 1996) . Phosphatidylinositol 3-kinase (PI 3-kinase) is implicated in the activation of Akt/AKT1 because an inhibitor of PI 3-kinase, wortmannin, or a PI 3-kinase dominant-negative mutant abolishes Akt/AKT1 catalytic activity (Franke et al., 1997; Hemmings, 1997) .
In contrast to the extensive amount of new information concerning the role of Akt/AKT1 in signal transduction, currently relatively little is known about the signaling activities of Akt2/AKT2. Franke et al. reported that human AKT2 kinase activity may be induced by PDGF (Franke et al., 1995) , although no data were shown to indicate if PI 3-kinase inhibitors can diminish PDGF-induced activation of AKT2.
We have suggested that AKT1 and AKT2 dier with regard to their involvement in human cancer. We and others have reported ampli®cation and/or overexpression of the AKT2 oncogene in 10 ± 20% of human ovarian (Cheng et al., 1992; Bellacosa et al., 1995) and pancreatic carcinomas (Cheng et al., 1996; Miwa et al., 1996) . In contrast, ampli®cation of AKT1 has been observed in only a single human gastric adenocarcinoma (Staal, 1987) . We also have demonstrated that AKT2 antisense RNA inhibits the tumorigenic phenotype of human pancreatic cancer cells exhibiting ampli®cation/overexpression of AKT2 (Cheng et al., 1996) , and that overexpression of AKT2 transforms NIH3T3 cells (Cheng et al., 1997) .
To elucidate the role of Akt2 in normal tissues as a prelude to studies in an animal model, we examined its expression during mouse development. Here we describe the ®rst detailed in situ hybridization analysis of endogenous Akt2 and, for comparison, Akt expression in embryonic mouse tissues. Mouse Akt is expressed at a higher level in the medulla oblongata (o), but at lower levels in the pons (p) and thalamus (th). Cardiac muscle (h) and whisker follicles (w) contain high amounts of Akt transcript, but Akt2 expression is more abundant in all skeletal muscles (arrowheads) and in liver (li). d=diaphragm,¯=forelimb, hl=hindlimb, i=intercostal muscle. (e ± h) Parasagittal sections of 16.5 d.p.c. embryos hybridized with probes for Akt (e, g) and Akt2 (f, h). Akt2 transcripts are abundant in skeletal muscle (arrowheads) and liver (li). Developing seminiferous tubules in the gonad (go) contain high levels of Akt2, but not Akt. Akt expression is detected in the central nervous system (n) and cervical ganglia (cg and arrows) where Akt2 mRNA levels are low. Akt2 transcript levels are very abundant in brown fat (f) of the cervical region compared to quantities in the surrounding tissue. c=cochlea, i=intercostal muscle, in=intestine, k=kidney, st=stomach. Scale bar A-H=500 microns. The probes for these in situ experiments were generated by subcloning the 1.4 kb open reading frame of Akt (Bellacosa et al., 1993) , the full-length 1.7 kb cDNA of Akt2 , or a 640 bp HincII cDNA fragment of Akt2 (encoding the 5' untranslated region and a portion of the PH domain) into pBluescript (Stratagene, La Jolla, CA). Sense and antisense transcripts were synthesized with 35 S-dUTP (41000 Ci/mmol; Amersham, Arlington Heights, IL). The section in D was hybridized with a 640 bp Akt2 transcript, whereas all other sections were probed with the 1.7 kb Akt2 transcript. No dierences were observed between the hybridization patterns of the two Akt2 probes. Tissue sections were hybridized overnight at 528C in 50% deionized formamide, 0.3 M NaCl, 20 mM Tris-HCl (pH 7.4), 5 mM EDTA, 10 mM sodium phosphate, 10% dextran sulfate, 16Denhardt's solution, 50 mg/ml total yeast RNA, 25 mmol/ml thioATP (Boehringer-Mann-heim, Indianapolis, IN), and 50 000 ± 75 000 c.p.m./ml 35 S-labeled probe. The tissue was subjected to stringent washing at 658C in 50% formamide, 26SSC, 10 mM DTT and washed in PBS before treatment with 20 mg/ml RNAse A at 378C for 30 minutes. Following washes in 26SSC and 0.16SSC each for 10 min at 378C, the slides were dehydrated, dipped in NTB-2 nuclear track emulsion (Kodak, Rochester, NY) and exposed for one week in light-tight boxes with desiccant at 48C. Photographic development was carried out in Kodak D-19 (Kodak, Rochester, NY). Slides were analyzed using both light-and dark®eld optics of a Zeiss Axiophot microscope embryos aged 9.5 days to 16.5 days post coitum (d.p.c.) were ®xed and embedded as previously described (Lyons et al., 1990) and hybridized to in vitro synthesized 35 S-dUTP-labeled transcripts of Akt and Akt2.
Both transcripts are expressed in a relatively uniform manner in the early embryo, although Akt mRNA levels are higher than Akt2 in the placenta. Dierences between the expression of the two homologues can be observed as early as 11.5 d.p.c., when Akt mRNA levels are high in the heart and neural tube, and Akt2 transcripts are abundant in myotomes and developing muscle masses and in the liver. Akt and Akt2 mRNAs are expressed at dierent levels in neural tissues, muscle and liver in all subsequent stages of embryonic development.
Dark®eld micrographs of 14.5 d.p.c. mouse embryos revealed that Akt is expressed at a high level in the medulla oblongata but at lower levels in the pons and thalamus (Figure 1a and b) . At this stage, the heart also expresses high amounts of Akt transcript. In contrast, Akt2 is abundantly expressed in skeletal muscle and liver (Figure 1c (Figure 1e and f) . At 16.5 d.p.c., Akt2 transcript levels are strikingly abundant in the brown fat of the cervical region compared to levels in the adjacent central nervous system and cervical ganglia (Figure 1g and h) .
Consistent with previously reported Northern analyses of adult tissue (Konishi et al., 1994; Altomare et al., 1995) , our in situ hybridization experiments demonstrate that Akt2 and Akt exhibit distinct tissuespeci®c expression throughout mouse development. The high levels of Akt2 expression, rather than Akt expression, in embryonic muscle and liver is also observed in the adult, as demonstrated by Northern blot analysis. The novel ®nding of elevated Akt2 expression in brown fat is noteworthy, because it is a tissue not readily accessible in the adult. Akt2 expression is much higher in brown fat than in any of the surrounding tissues, including skeletal muscle. Brown fat is unique due to its thermogenic characteristic, although both brown and white adipocytes exhibit similar properties of cellular dierentiation and adipose conversion (reviewed in Klaus, 1997) . In situ expression of Akt2 was low in the white fat surrounding ovaries in adult mice.
New information concerning the localization of Akt2 transcripts in certain specialized cells within whole organs was obtained when selected adult mouse tissues were examined by in situ hybridization. For example, although Northern blot analysis detects overall low Akt2 transcript levels in mouse adult brain , in situ studies reveal that Purkinje cells in the adult cerebellum highly express Akt2 mRNA compared to the surrounding granule cell layer (Figure 2) . Interestingly, Purkinje cells have been postulated to actively respond to insulin, because in situ hybridization also has revealed high mRNA levels of the insulin-regulatable glucose transporter 4 in these specialized neurons (Kobayashi et al., 1996) . In addition to hindbrain and cerebellum, we examined the levels of Akt2 and Akt in other areas of the brain such as the cortex, hippocampus and thalamus. The levels of expression of Akt2 were lower than those of Akt in each of these areas.
Overall, the tissue-speci®c expression studies indicate that, in comparison to Akt, Akt2 is preferentially transcribed in tissues targeted by insulin; i.e., brown fat, skeletal muscle and liver. Further evidence in support of this contention was derived from in vitro studies of Akt2 and Akt in mouse 3T3-L1 preadipocytes and C2C12 myoblasts (Figure 3 ). Northern analyses demonstrated that Akt2, but not Akt, is increased in dierentiating fat and muscle cells in vitro. Similarly, we previously had shown elevated Akt2 transcript levels in dierentiating Myod-transformed 10T 1/2 ®broblasts expressing myocyte-speci®c markers , whereas Akt expression remained unchanged in dierentiating Myod-transformed 10T 1/2 cells (not shown).
The Northern analyses presented here clearly demonstrate that Akt2 is highly expressed in two murine cell lines commonly used for delineating insulin-mediated signaling and cellular dierentiation pathways. The high expression of Akt2, as compared to Akt, suggests that Akt2 may play a prominant role in mature fat and skeletal muscle cells, and furthermore, that Akt2 and Akt are regulated dierently at the transcriptional level in certain cell-types. It is presently unknown if this dierential regulation can be attributed to dierences in uncharacterized promoter elements or transcriptional turnover rates.
Although Akt2 and Akt may exhibit dierences in their transcriptional regulation, the protein-serine/ threonine kinases encoded by these genes may participate in similar signal transduction cascades, because Akt2 and Akt proteins exhibit a high degree of sequence and predicted structural homology . Several groups have demonstrated that Akt/AKT1 is activated by insulin through a PI 3-kinase-dependent pathway (Alessi et al., 1996; Burgering and Coer, 1995; Cross et al., 1995 Cross et al., , 1997 Kohn et al., 1995) . However, we and others (A Bellacosa, personal communication) have noted that only anti-Akt/AKT1 and anti-Akt2/AKT2 antibodies against speci®c epitopes can be used to distinguish the same-mobility bands of endogenous Akt and Akt2 run on SDS ± PAGE. Similarly, Cross et al. (1995) performed a chromatographic analysis to demonstrate that Akt/AKT1 phosphorylates glycogen synthase kinase-3 peptide, but also proposed that a prominent protein fraction not immunoprecipitated by anti-Akt/ AKT1 speci®c antibodies may represent Akt2.
To determine if the activation of Akt2/AKT2 by insulin is mediated through PI 3-kinase, we transfected 3T3-L1 cells with a HA-AKT2 construct. We observed three bands with similar mobilities which may be indicative of dierent phosphorylation states on immunoblots screened with anti-HA antibodies (Figure 4) . Repeatedly, only insulin-stimulated 3T3-L1 cells exhibited the slowestmobility band that is presumed to be the fully phosphorylated, activated form of HA-AKT2 (Mitsuuchi et al., in preparation). Moreover, the kinase activity of AKT2 as measured by the phosphorylation of histone H2B increased approximately twofold in response to insulin treatment (Figure 4 ). The addition of wortmannin, an inhibitor of PI 3-kinase, abolished the insulin-dependent activation of AKT2, thus implying that AKT2 activation by insulin is mediated through PI 3-kinase. In addition, recent transient transfection experiments with HA-tagged constructs Figure 4 AKT2 kinase activity is stimulated by insulin and inhibited by wortmannin. 3T3-L1 cells were transfected with a HA-tagged AKT2 construct (Mitsuuchi et al., in preparation) and then serum-starved for 18 h on the following day. The cells were pre-incubated for 30 min at 378C in serum-free DMEM with (+) or without (7) 100 nM wortmannin. Subsequently, the cells were incubated for 15 min in serum-free DMEM with or without 200 nM insulin. Following SDS ± PAGE and transfer to Hybond C-Super (Amersham, Arlington Heights, IL), HA-AKT2 protein expression was assayed by immunoblotting with anti-HA monoclonal antibody (BabCO, Richmond, CA). Bands c, b, and a corresponded to relative molecular masses (M r ) of 60K, 59K and 58K, respectively. Kinase activity of AKT2 was quanti®ed by histone H2B phosphorylation in the presence of [g-32 P]ATP. In brief, treated cells were washed with ice-cold PBS and lysed in buer (50 mM Tris (pH 7.5), 137 mM NaCl, 10% glycerol, 1 mM EDTA, 1 mM PMSF, 2 mg/ml of aprotinin, 2 mg/ml leupeptin, 1 mM sodium vanadate, 20 mM b-glycerolphosphate, 50 mM NaF, 10 mM sodium pyrophosphate, and 1% NP-40). The lysates were centrifuged for 10 min at 14 0006g at 48C and pre-cleared by mixing with protein A agarose at 48C for 20 min. Following the removal of the beads by centrifugation, the lysates were incubated with anti-HA antibody, and protein A-protein G (1 : 1) agarose beads were used to precipitate the immune complexes. After extensive washing of the beads, protein kinase reactions were carried out at room temperature for 25 min in the presence of [g-32 P]ATP, 5 mM cold ATP and Histone H2B. The reactions were stopped by the addition of SDS ± PAGE loading buer (120 mM Tris-HCl (pH 6.8), 100 mM DTT, 3% SDS, 10% glycerol, 0.02% bromophenol blue), samples were separated by SDS ± PAGE, and the radioactivity of each protein band was analysed by Fuji Bioimaging Analyzer BAS2000. The ®gures are representative of experiments run in triplicate. Mouse 3T3-L1 and C2C12 cells were obtained from the American Type Culture Collection and maintained for growth and dierentiation as previously described (Reed and Lane, 1980; Guo et al., 1995) . RNA was extracted using guanidinium thiocyanate method or with an RNeasy Total RNA kit (Qiagen Inc., Chatsworth, CA). The RNA was electrophoretically fractionated through formaldehyde-agarose gels and transferred to a GeneScreen Plus (Dupont NEN, Wilmington, DE) membrane. The Northern blots were hybridized and washed as described previously .
demonstrated that the inhibition of glycogen synthase kinase-3 by insulin is mediated by Akt2, as well as Akt (Mitsuuchi et al., in preparation).
In conclusion, this is the ®rst report linking high Akt2 expression to highly insulin-responsive tissues, particularly brown fat, during embryonic development. Furthermore, our data indicate that Akt2/ AKT2 is activated by insulin in vitro and that this activation appears to be mediated by PI 3-kinase. These experiments provide the basis for further study of Akt2/AKT2 signaling, particularly with regard to the delineation of events downstream of activated Akt2.
